Natixis
- SEC CIK
- 0001274981
- Latest filing
- Aug 13, 2026
CHRS holding history
Coherus Oncology, Inc. in every 13F filed by Natixis, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CHRS overviewAll 13F holders of CHRSFull Q2 2026 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 1
- Since Q3 2022